Clinical Trials in New York

Showing 2501-2520 of 10,830 trials

An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa

NCT06518941

The purpose of this study is to test the feasibility and tolerability of donepezil in a small group of patients with anorexia nervosa (AN). Study participants will be receiving care at the New York State Psychiatric Institute Eating Disorders Unit. Study medication will be increased from 1 mg per day to a maximum of 5 mg per day for up to 8 weeks. Participants will be closely monitored for side effects by a research psychiatrist every week, in addition to the regular clinical monitoring they receive during inpatient treatment. The study will also include assessments of habit strength to measure any changes in maladaptive eating habits over the course of the treatment.

Anorexia Nervosa

New York State Psychiatric Institute10 participantsStarted Jun 2026

New York, New York, United States

RECRUITINGNA< 1 mile

Pericardiotomy in Cardiac Surgery

NCT06486636

PRINCE is an international, multicentre, randomized controlled trial of posterior pericardiotomy in patients without a history of atrial fibrillation (AF) or flutter undergoing cardiac surgery.

Atrial FibrillationAtrial FlutterCardiac Events

Population Health Research Institute1,400 participantsStarted Oct 2024

New York, New York, United States • Vienna, Vienna, Austria • Hamilton, Ontario, Canada +1 more locations

An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa

Pericardiotomy in Cardiac Surgery

Find Trials by Condition in New York

Cognitive Markers in Prodromal MS

Persuasive Health Communication Intervention for HIV/HCV

Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling

A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder

A Study in Participants With Non-cirrhotic NASH With Fibrosis

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

A Study of JNJ-55308942 in the Treatment of Bipolar Depression

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

Observational Maternal COVID-19 Vaccination Study

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma

Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)